StockDuty ← Dashboard Aug 12, 2026 01:44 PM ET
CatalystFDA/Bio

Cardiff Loss Narrows In Q2; Directs Resources To Phase 3 For Onvansertib In Q1 '27

Cardiff Loss Narrows In Q2; Directs Resources To Phase 3 For Onvansertib In Q1 '27

Sources